Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, order wins, and acquisitions, here’s a quick look at which stocks will be in focus in today's trade:Quarterly Earnings (Provisional Updates)IndusInd Bank Q4 (YoY)Net advances grow 1.4% to Rs 3.47 lakh crore Vs Rs 3.43 lakh croreDeposits increase 6.8% to Rs 4.11 lakh crore Vs ...

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, order wins and acquisitions, here’s a quick look at which stocks will be in focus in today's trade:Results TodayWipro, Tech Mahindra, SBI Life Insurance Company, ICICI Lombard General Insurance Company, Indian Hotels, Jio Financial Services, 5paisa Capital, Aether Industries,...

Indian equity markets are likely to open in the red as trends in the SGX Nifty indicated at a negative opening for benchmark indices in India with a loss of 85 points. In the previous session, the BSE Sensex fell 652 points to 59,646, while the NSE Nifty 50 slipped 198 points to 17,758 and formed a bearish Engulfing pattern on the daily charts. “17,300-17,600 zone would provide a cushion in ...

WHO chief Tedros Adhanom Ghebreyesus discussed the issue of the emergency use listing of Bharat Biotech's COVID-19 vaccine Covaxin and resumption of supplies of the Serum Institute of India-manufactured AstraZeneca vaccine to the COVAX facility among other topics during a telephonic conversation with Health Minister Mansukh Mandaviya.“Had a call with @mansukhmandviya, India's Health Minister, to...

AstraZeneca NSE 0.32 % has requested emergency use authorisation from U.S. regulators for its new treatment to prevent COVID-19 for people who respond poorly to vaccines because of a weakened immune system.In a statement on Tuesday, the Anglo-Swedish drugmaker said it included data in its filing with the Food and Drug Administration from a late-stage trial that showed the drug reduced the risk of...